A Preview Of Accelerate Diagnostics's Earnings
Portfolio Pulse from Benzinga Insights
Accelerate Diagnostics (NASDAQ:AXDX) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts expecting an EPS of $-0.62. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss resulting in a 2.88% drop. Shares are currently trading at $0.9603, marking an 86.34% decline over the last year. Investors are looking for positive guidance for the next quarter.
March 27, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Accelerate Diagnostics is expected to report an EPS of -$0.62 for the quarter. Historical performance shows variable stock price reactions to earnings reports. Currently, shares are significantly down over the year.
Given the expected EPS and historical performance, the short-term impact on AXDX's stock price could be neutral. However, the guidance provided may play a crucial role in determining the stock's direction. The significant annual decline indicates that investors may be cautious.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100